Progesterone Receptor Negative Active Not Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02432963Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior TherapyTreatment